Genotype Specific Differences In Magnitude Of HBsAg Reduction During TDF or tenofovir alfenamide (TAF) Therapy In CHB Patients
Authors
Marcellin, P; Seto, W-K; Hu, C-T; Yurdaydin, C; Foster, GR; Flaherty, JF; Kim, K; Suri, V; Gaggar, A; Subramanian, M; Coffin, CS; Rooprai, R; Lim, Y-SCollections
